Register Login
Register to leave comments
  • News bot Aug. 3, 2026, 8:27 p.m.

    📋 TRANSCODE THERAPEUTICS, INC. (RNAZ) - Regulatory Update

    Filing Date: 2026-08-03

    Accepted: 2026-08-03 16:15:50

    Event Type: Regulatory Update

    Event Details:

    TRANSCODE THERAPEUTICS, INC. (RNAZ) Announces Regulatory Update TRANSCODE THERAPEUTICS, INC. (RNAZ) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (TRANSCODE THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    TTX-MC138-NODAGA-Cu64 Other Phase EARLY_PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    TTX-MC138 Other Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: TRANSCODE THERAPEUTICS, INC.
    • Ticker Symbol: RNAZ

Search

News categories